Dignitana AB Publishes Q3 2022 Interim Report
Accelerated growth and extraordinary customer satisfaction Financial highlights Q3 2022 · Net sales amounted to 18.6 MSEK (13.7), an increase of 36 percent over the same period in 2021. · Operating result amounted to -3.6 MSEK (-13.6). · Net result after financial items amounted to -3.7 MSEK (-13.9). · Earnings per share were -0,06 SEK (-0,21). · Cash Balance amounted to 6.7 MSEK (21.0). · Average Daily Treatment Revenue (ADTR)* was 203 TSEK (147), an increase of 38 percent over the same period in 2021. Business highlights during the period · Dignitana